Related Experiment Video

Updated: Mar 17, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis

Chan Kim1, Hannah Yang2, Intae Park2

  • 11. Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea;; 2. Laboratory of Tumor Vasculature and Microenvironment, CHA University, Seongnam, Korea;

Journal of Cancer
|July 30, 2016
PubMed

Insights

RhoJ, a Rho GTPase, promotes gastric cancer (GC) progression and metastasis. High RhoJ expression indicates poor survival and increased cell motility, suggesting it as a negative prognostic factor for GC patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Rho GTPases are crucial for tumor cell migration and invasion.
  • The role of Rho GTPases in gastric cancer (GC) pathogenesis is largely unknown.
  • RhoJ is an understudied member of the Rho GTPase family.

Purpose of the Study:

  • To investigate the clinical significance and functional role of RhoJ in gastric cancer.
  • To determine if RhoJ expression correlates with GC progression, metastasis, and patient survival.

Main Methods:

  • Analysis of RhoJ expression in GC cell lines and patient tumor samples.
  • In vitro gain-of-function studies to assess RhoJ's impact on GC cell phenotypes.
  • Correlation analysis between RhoJ expression and clinical parameters, including survival and recurrence.

Main Results:

  • RhoJ expression varied across GC cell lines and patient tissues.
  • High RhoJ expression was associated with diffuse type GC, advanced stages, and increased metastasis.
  • Elevated RhoJ levels significantly correlated with poorer overall and recurrence-free survival.
  • RhoJ overexpression enhanced GC cell motility (41.3%) and invasiveness (60.4%) without affecting proliferation.

Conclusions:

  • High RhoJ expression is an independent negative prognostic factor for gastric cancer survival.
  • RhoJ promotes GC progression and metastasis by increasing cell motility and invasiveness.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K